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AVFAbstract Endovascular treatment of the malfunctioning fistula can involve a combination of
angioplasty, stenting and the use of thrombolysis with low reported mortality and morbidity.
The primary aim of the study was to determine the primary patency and primary assisted patency
rates of angioplasty for the treatment of perianastomotic stenosis of renal dialysis arterio-venous
fistulas (AVFs). The secondary purposes were to identify the factors that may impact restenosis rate
and to evaluate the need for close surveillance of AVF. This is a retrospective analysis of AVF
angioplasty for peri-anastomotic stenosis. Between August 2009 and March 2012, 44 patients with
autologous AVF were treated with percutaneous transluminal angioplasty (PTA). The technical
success rate was 100%. 23 of the 44 patients (52.3%) required repeated intervention during the
follow-up period. Our primary patency rate at 1 year was 62.5% and the primary assisted patency
rate was 96.9% at 1 year. No immediate post-procedure complications.
Conclusion: Endovascular management of peri-anastomotic stenosis in renal dialysis AVF is an
effective approach with low morbidity and mortality rates. The higher primary assisted patency
compared to the primary patency rate emphasizes the need for close surveillance of AVF and
low threshold for early re-intervention.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
The increasing number of patients with end-stage renal disease
has broadened the need for reliable vascular access (1).
Since the advent of hemodialysis in 1944 and the subse-
quent use of AVF as a long-term vascular access, there has
been a drastic increase in both the availability of hemodialysisand long-term survival of patients with chronic renal failure
(2).
Either a radio-cephalic or brachiocephalic AVF created
using the patient’s native vein provides the best possible vascu-
lar access for hemodialysis (3).
Two factors are necessary for an AVF to be usable as dial-
ysis access; it must have adequate blood flow, and it must have
a size that will allow for cannulation (4).
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maturation of fistulas that fail to mature and enhancing the
long-term patency of mature fistulas (5).
Dysfunction of AVF occurs frequently in hemodialysis
patients and contributes significantly to morbidity and hospi-
talization in the dialysis population (3).
Early fistula failure is frequently due to anatomic lesions
that may exist anywhere within the access circuit. Arterial
inflow lesions include anatomically small vessels and
atherosclerotic disease, which are found in an increasing por-
tion of the elderly, and patients with hypertension and dia-
betes. Arteriovenous anastomotic and venous swing point
stenoses are commonly seen acquired lesions, as these are the
sites of surgical creation and mobilization of the artery and
vein. Venous outflow and central venous lesions, may be due
to pre-existing anomalies, such as anatomically small veins,
fibrotic or stenotic veins, or sites of prior puncture or catheter
placement. In addition, venous outflow problems may be due
to accessory veins or side branches (6–9).
A reduction of vessel diameter 50% associated with a
reduction in access flow during dialysis or previous thrombo-
sis, indicates the need for intervention. In radiocephalic
AVF, 55–75% of stenoses are located close to the AV anasto-
mosis and 25% in the outflow tract (10,11).
The traditional therapy for failing hemodialysis access has
been surgical revision where a patch of angioplasty is usually
performed to correct vascular narrowing due to a venous anas-
tomosis stenosis (12).
These stenoses can also be treated by percutaneous translu-
minal angioplasty (PTA) whose main advantages are usually a
better preservation of the venous capital, immediate availabil-
ity of the fistula for dialysis, and a slightly less invasive nature.
Although many studies have reported the results of angio-
plasty or surgery in the management of failing AVF, few stud-
ies have specifically evaluated these anastomotic stenoses (13).
Therefore, the primary aim of the study was to determine
the primary and primary assisted patency rates of endovascu-
lar management in the treatment of perianastomotic stenosis
of renal dialysis AVF. The secondary purposes were to identify
the factors that may impact restenosis rate and to evaluate the
need for close surveillance of AVF.Fig. 1a 6 French sheath retrograde insertion in left cephalic vein. 5 F
at the perianastomotic segment of the radio-cephalic AVF.2. Materials and methods
This is a retrospective analysis of AV fistula angioplasty for
peri-anastomotic stenosis.
Between August 2009 and March 2012, 44 patients (27 men,
17 women), aged 36–89 years with a mean of 64.3 ± 14.4 years
with autologous AVF were treated with percutaneous angio-
plasty. 25 patients had a radio-cephalic AVF, 14 had a bra-
chiocephalic AVF and 5 had brachiobasilic AVF.
10 procedures were performed on non-maturing fistulas in
patients who were not yet on dialysis. One patient had a
mature fistula, but did not start dialysis yet.
Patients were diagnosed with AVF stenosis during surveil-
lance Doppler ultrasound or referred by nephrologists.
All patients had a Doppler ultrasound examination first to
assess patency and flow volume of the AVF. The Doppler cri-
teria for intervention included the following: 1. Visible lumen
narrowing on gray scale ultrasound and aliasing on color
Doppler at the site of stenosis; 2. Fistula flow volume of
<400 ml/min in pre-dialysis fistula; and <600 ml/min in
patients on dialysis.
The procedure was performed under local anesthesia.
Retrograde puncture of the outflow vein of the AV fistula
was performed in all cases in a standard Seldinger technique,
and a 6 Fr sheath was inserted. The peri-anastomotic stenosis
was negotiated with a 0.035-in. hydrophilic-coated guide-wire
and a diagnostic catheter, followed by the balloon catheter
passed over the guide-wire. The size of the balloon chosen
was depending on the diameter of the normal vessel adjacent
to the area to be dilated. The balloon sizes used in our study
ranged from 4 to 10 mm with 6 mm balloon being the most
commonly used size. Under pressure control, the balloon
was inflated slowly until the waist disappeared (Fig. 1).
We inserted Misago (Terumo, Tokyo, Japan) self-
expandable metallic stents in the primary setting in 7 cases
due to vessel re-stenosis after balloon angioplasty. The stents’
sizes were either 7 or 8 mm in diameter and all were 40 mm in
length.
All patients were on surveillance program, and the routine
is to have the first Doppler examination one monthrench catheter in left radial artery. Angiogram shows tight stenosis
Fig. 1b 6 mm  4 cm balloon inflated at the site of the perianastomotic stenotic segment of the radio-cephalic AVF.
Fig. 1c Completion angiogram through 5 French catheter in left radial artery shows good angiographic result of balloon angioplasty
with no residual stenosis at the perianastomotic segment of the radio-cephalic AVF.
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were lost for follow-up.
Data were fed to the computer and analyzed using IBM
SPSS software package version 20.0. Qualitative data were
expressed using number and percent. Quantitative data were
tested for normality and were expressed in mean ± SD. Signif-
icance of the obtained results was judged at the 5% level.
3. Results
The technical success rate was 100%. Our criterion for techni-
cal success was achievement of less than 30% angiographic
residual stenosis. The diameter of the stenotic vessel was mea-
sured on the workstation of the angiography machine after
angioplasty and was compared to the diameter of the adjacent
normal vessel, and a decrease of 30% or less in the diameter of
the angioplastied vessel was considered a technical success.
Confirmation with on-table Doppler examination was not
always required.
No immediate post-procedure complications were
encountered in terms of fistula rupture, significant hematoma
or fistula thrombosis. No 30-day mortality was reported.23 of the 44 patients (52.3%) required repeated intervention
during the follow-up period; 19 had repeated balloon angio-
plasty, 3 had angioplasty and stent insertion, and 1 patient
had insertion of a new stent within the initially inserted stent.
20 of the 44 patients did not require further intervention dur-
ing the follow-up period. Only one patient (2.3%) presented
after 6 days with thrombosed AVF. The period between pri-
mary and re-intervention ranged from 1 to 35 months with
an average of 13 months.
The follow-up period ranged from 12 to 42 months in the
form of Doppler examination and clinical follow-up during
dialysis. 5 patients had a successful renal transplant after at
least one year of the procedure, where the fistula was still func-
tioning well.
Primary patency is defined as uninterrupted patency with-
out any additional procedure of the previously treated lesion.
The mean primary patency of the whole study group was
12.6 ± 9.5 months ranging from 6 days to 35 months.
12 patients died before completing 1 year of follow-up,
while 32 of the 44 patients were alive for a year or more.
The primary patency rate at 1 year was calculated among those
32 patients.
Table 1 Relation between re-stenosis and different
parameters.
Re-stenosis p
No (n= 21) Yes (n= 23)
Age (years) 62.14 ± 14.42 66.17 ± 17.38 0.359
670 15 (71.4%) 12 (52.2%) 0.190
>70 6 (28.6%) 11 (47.8%)
Sex
Male 13 (61.9%) 14 (60.9%) 0.944
Female 8 (38.1%) 9 (39.1%)
Pre-dialysis 5 (23.8%) 6 (26.1%) 0.862
Diabetes 5 (23.8%) 7 (30.4%) 0.622
Hypertension 4 (19.0%) 6 (26.1%) 0.724
Stenosis of anastomosis 7 (33.3%) 17 (73.9%) 0.007*
Stent insertion 2 (9.5%) 5 (21.7%) 0.416
Qualitative data were expressed using number and percent and
were compared using Chi Square or Fisher’s Exact test. Normally
quantitative data were expressed in Mean ± SD and were com-
pared using Student’s t-test.
* Statistically significant at p 6 0.05.
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mary intervention with no further re-intervention; the primary
patency rate at 1 year was 62.5%.
Primary assisted patency is whereby patency is never lost
but is maintained by prophylactic intervention.
The mean primary assisted patency of the whole study
group was 19 ± 10.6 months and the longest patency was
41 months.
Primary assisted patency rate at 1 year was 96.9%, meaning
that among the 32 patients alive for a year or more, 31 patients
had patent AVF after 1 year with repeated intervention.
Only one fistula thrombosed after 6 days of angioplasty.
Self-expandable metal stents were inserted in 7 of the 44
patients in the primary setting with average primary patency
of 9 months. 5 patients of the 7 required re-intervention with
balloon angioplasty due to in-stent stenosis, and the average
primary assisted patency was 21.4 months.
The mean flow volume through the inflow artery prior to
fistuloplasty was 400 ml/min, and at 1-month post-procedure
follow-up the mean volume was 840 ml/min.
Patient characteristics including age, gender, patient on
dialysis or pre-dialysis, comorbidities, stenosis of the anasto-
mosis, and stent insertion were studied in relation to recur-
rence of stenosis. No statistical significance was found in all
factors apart from involvement of the anastomotic site in the
stenosis; this was found to be statistically significant
(p= 0.007). (Table 1).
4. Discussion
There is an increasing demand for reliable, long-term
hemodialysis access and as life expectancy in patients with
renal failure rises, there will be increasing need for techniques
to maintain patency of AVF. The limitations of failure to
mature, stenosis and occlusion pose important clinical chal-
lenges in providing long-term dialysis access (14,15).
Patients may require the formation of several fistulas over
their life and this can eventually lead to problems in findingsuitable access vessels. Preservation of existing fistulas by sur-
gical or endovascular means therefore offers a logical
approach wherever possible. Endovascular treatment of the
malfunctioning fistula can involve a combination of angio-
plasty, stenting and the use of thrombolysis with low reported
mortality and morbidity (14).
In our study, the technical success rate was 100% in 44
patients, this compared to Coskun et al. (1); where PTA was
successful in 20 of the 24 patients (83.33%) with first-time
dilated stenoses. Long et al. (13) also reported a technical suc-
cess rate of 92.3%.
Our primary patency (PP) rate at 1 year was 62.5% and the
primary assisted patency (PAP) rate was 96.9% at 1 year. This
is compared to Long et al. (13), who reported PP rate of 41%
at 1 year and a PAP rate of 92% at 1 year. The difference
between the PP and PAP rates illustrates the value of post-
angioplasty surveillance scheme and early re-intervention to
maintain the AVF patency.
From the available patient’s records we studied the factors
which could have an impact on the re-stenosis rate including
patient’s factors such as age, sex, diabetes and hypertension
and pre-interventional factors including stenosis of the anasto-
mosis itself and the AVF being used for dialysis or still a pre-
dialysis patient as well as usage of a stent intra-operatively or
not. We could not find full record of smoking habits for all
patients. Only one variable was independent risk factor for
stenosis recurrence: stenosis site at the anastomosis itself
(73.9% confidence interval (CI), p= 0.007). This is compared
to Long et al. (13) who found stenosis site at the anastomosis
itself as a significant risk factor (95%, P= .005).
Several complications are known to occur in 2–6% of cases,
including venous rupture, the formation of pseudoaneurysms,
acute access thrombosis, bacteremia, and contrast material
reaction (1). No immediate post-procedure complications were
encountered in our series, in terms of fistula rupture, signifi-
cant hematoma or fistula thrombosis.
5. Conclusion
Endovascular management of peri-anastomotic stenosis in
renal dialysis AVF is an effective approach with low morbidity
and mortality rates. The higher primary assisted patency com-
pared to the primary patency rate emphasizes the need for
close surveillance of AVF and low threshold for early re-
intervention. Stenosis of the surgical anastomosis is a signifi-
cant risk factor for recurrence of stenosis.
It is recommended that patients on dialysis through an
AVF should be on a close surveillance scheme including clini-
cal and Doppler evaluation from the time of creation of the fis-
tula and throughout their life to detect signs of dysfunction
and allow early intervention.
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